Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL14811730 | 0.98 | KDM4E (0.40) | KDM4EACHEBCHEHDAC8 | |
| SCHEMBL28886151 | 0.93 | KDM4E (0.37) | KDM4E | |
| Hydrochloric Acid SCHEMBL3479419 | 0.81 | KDM4E (0.46) | KDM4EACHEBCHEHDAC8 | |
| SCHEMBL2732035 | 0.79 | CYP2D6 (0.41) | KDM4EACHEBCHE | |
| SCHEMBL17968399 | 0.79 | KDM4E (0.38) | KDM4EACHEBCHE | |
| Hydrochloric Acid SCHEMBL17968398 | 0.78 | KDM4E (0.41) | KDM4EACHEBCHE | |
| Hydrochloric Acid SCHEMBL1395436 | 0.78 | KDM4E (0.41) | KDM4EACHEBCHE | |
| SCHEMBL3087633 | 0.77 | KDM4E (0.44) | KDM4EACHEBCHEHDAC8 | |
| SCHEMBL18035808 | 0.77 | NPC1 (0.41) | KDM4EACHEBCHEHDAC8 | |
| SCHEMBL15174433 | 0.77 | KDM4E (0.36) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10814317-B2 | Hydrocarbon processes using halometallate ionic liquid micro-emulsions | UOP LLC (US) | 2020-10-27 | — | — | US | claimed |
| US-10596561-B2 | Halometallate ionic liquid micro-emulsions | UOP LLC (US) | 2020-03-24 | — | — | US | claimed |
| EP-3548574-A1 | ABRASION RESISTANT COATING COMPOSITION WITH INORGANIC METAL OXIDES | Momentive Performance Materials Inc. (US) | 2019-10-09 | — | — | EP | claimed |
| EP-3480881-A1 | ELECTROLYTE BASED ON SULFUR/POLYSULFUR FOR LITHIUM/SULFUR BATTERIES | Fundación Cidetec (ES) | 2019-05-08 | — | — | EP | claimed |
| US-20190001314-A1 | HYDROCARBON PROCESSES USING HALOMETALLATE IONIC LIQUID MICRO-EMULSIONS | UOP LLC | 2019-01-03 | — | — | US | claimed |
| WO-2018102509-A1 | ABRASION RESISTANT COATING COMPOSITION WITH INORGANIC METAL OXIDES | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2018-06-07 | — | — | WO | claimed |
| US-20180148600-A1 | ABRASION RESISTANT COATING COMPOSITION WITH INORGANIC METAL OXIDES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2018-05-31 | — | — | US | claimed |
| EP-2759016-B1 | ADDITIVES FOR HYDROGEN/ BROMINE CELLS | BROMINE COMPOUNDS LTD (IL) | 2017-03-29 | — | — | EP | claimed |
| WO-2016161203-A1 | OLEFIN OLIGOMERIZATION PROCESSES USING HALOMETALLATE IONIC LIQUID MICRO-EMULSIONS | UOP LLC (US) | 2016-10-06 | — | — | WO | claimed |
| WO-2016161197-A1 | HYDROCARBON PROCESSES USING HALOMETALLATE IONIC LIQUID MICRO-EMULSIONS | UOP LLC (US) | 2016-10-06 | — | — | WO | claimed |
| US-7488860-B2 | Method for producing exo-tetrahydrodicyclopentadiene using ionic liquid catalyst | CHINESE PETROLEUM CORP. (TW) | 2009-02-10 | — | — | US | claimed |
| US-20080319241-A1 | METHOD FOR PRODUCING ADAMANTANE | CPC CORPORATION, TAIWAN | 2008-12-25 | — | — | US | claimed |
| US-20080064909-A1 | Method for producing exo-tetrahydrodicyclopentadiene using ionic liquid catalyst | CHINESE PETROLEUM CORP. (TW) | 2008-03-13 | — | — | US | claimed |
| US-7326493-B2 | Lithium electrochemical generator comprising at least a bipolar electrode with conductive aluminium or aluminium alloy substrates | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-02-05 | — | — | US | claimed |
| US-20050069768-A1 | Lithium electrochemical generator comprising at least a bipolar electrode with conductive aluminium or aluminium alloy substrates | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2005-03-31 | — | — | US | claimed |
| CN-1596483-A | Lithium electrochemical generator comprising at least a bipolar electrode with conductive aluminium or aluminium alloy substrates | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2005-03-16 | — | — | CN | claimed |
| EP-1493202-A2 | LITHIUM ELECTROCHEMICAL GENERATOR COMPRISING AT LEAST A BIPOLAR ELECTRODE WITH CONDUCTIVE ALUMINIUM OR ALUMINIUM ALLOY SUBSTRATES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2005-01-05 | — | — | EP | claimed |
| WO-2003047021-A2 | LITHIUM ELECTROCHEMICAL GENERATOR COMPRISING AT LEAST A BIPOLAR ELECTRODE WITH CONDUCTIVE ALUMINIUM OR ALUMINIUM ALLOY SUBSTRATES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2003-06-05 | — | — | WO | claimed |
| EP-0596395-B1 | Process for the preparation of fluorinated benzil | CLARIANT GMBH (DE) | 2000-06-28 | — | — | EP | claimed |
| EP-0466026-A2 | Biodegradable polymers | MITSUBISHI RAYON CO., LTD (JP) | 1992-01-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10596561-B2 | Halometallate ionic liquid micro-emulsions | MITF, MED12, LIPA | KDM4E 4115/4885ACHE 2774/4885BCHE 1534/4885 |
| US-10814317-B2 | Hydrocarbon processes using halometallate ionic liquid micro-emulsions | MED12, MITF, SUB1 | KDM4E 3456/4885ACHE 2923/4885BCHE 1345/4885 |
| US-20190001314-A1 | HYDROCARBON PROCESSES USING HALOMETALLATE IONIC LIQUID MICRO-EMULSIONS | MED12, MITF, SUB1 | KDM4E 3456/4885ACHE 2923/4885BCHE 1345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.